The Nanotech Company Co-Founder Wins 2005 Japan Prize

The Company's Co-Founder and Scientific Advisory Board Chairman, Erkki

Ruoslahti, M.D. PhD, Will Receive the 2005 Japan Prize

Jan 13, 2005, 00:00 ET from Nanotech Company, LLC

    SAN DIEGO, Jan. 13 /PRNewswire/ -- The Nanotech Company, LLC, a leading
 small tech advisory firm, is proud that the company's Co-Founder and
 Scientific Advisory Board Chairman, Erkki Ruoslahti, M.D. PhD, will receive
 the 2005 Japan Prize. The award is given for his decisive role in elucidating
 the molecular mechanism of cell-to-extracellular matrix adhesion.
     The Japan Prize (and cash award) is presented at a rare public appearance
 of the Emperor at the focus of a one-week celebration.
     Dr. Ruoslahti said, "I am thrilled and honored to be receiving this
 prestigious prize. It is in recognition of work done about 20 years ago when
 we showed that a 3 amino acid chemical motif is the key structure for cell
 attachment. Compounds that contain this so-called RGD peptide motif are used
 in the clinic to prevent blood clotting, and RGD drugs for other uses are
 under development. My particular current interest is to use RGD and other
 peptides to build 'smart' nanoparticles that can deliver drugs to tumors."
     Darrell Brookstein, Managing Director and Co-Founder of The Nanotech
 Company, LLC said, "This international award for scientific achievement and
 service to humanity is in recognition of Dr. Ruoslahti's work in biology. Many
 winners have been awarded the Nobel. We wish our SAB Chairman the heartiest of
 congratulations and look forward to the early results of his current nano-
 medicine work."
     The Japan Prize is awarded for original and outstanding achievements in
 science and technology that are recognized as having advanced the frontiers of
 knowledge and served the cause of peace and prosperity for mankind.
     The Nanotech Company, LLC ensures that emerging small tech companies
 achieve their corporate development goals by accessing its significant
 scientific, corporate development, and financial advisory resources. Managing
 Director, Darrell Brookstein, a 30 year financial executive, and Erkki
 Ruoslahti, M.D., Ph.D., a Distinguished Professor and bionanoscientist, have
 assembled an eminent team of specialists to enhance and accelerate the
 intelligent growth of small tech companies.
     The company publishes a free weekly e-digest of nanotech news, and
 Nanotech Fortunes. For information, visit .
      Darrell Brookstein
      The Nanotech Company
     This press release was distributed by PRWEB
 ( ), a service of eMediawire.

SOURCE Nanotech Company, LLC